Korro Bio, Inc. (KRRO) vs Polaryx Therapeutics, Inc. Common Stock (PLYX)

A side-by-side comparison of Korro Bio, Inc. and Polaryx Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Korro Bio, Inc. logo
KRRO
Korro Bio, Inc.
$97M
$9.71HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
Polaryx Therapeutics, Inc. Common Stock logo
PLYX
Polaryx Therapeutics, Inc. Common Stock
$104M
$2.09HealthcareDelayed quote: Oct 6, 2026, 2:02 PM EDT

Total return — KRRO vs PLYX

growth of $100 · dividends reinvested · last 1y
KRRO -23.6% (-23.6%/yr)PLYX -94.1% (-94.1%/yr)KRRO compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100$76$6
KRRO PLYX

KRRO vs PLYX: by the numbers

  • •PLYX is the larger company ($104M vs $97M market cap).
  • •Both run net losses; PLYX's is the smaller (0.00% vs -4477.08% net margin).

Metrics side by side

Valuation

MetricKRROPLYX
P/S ratio40.57N/A
P/B ratio0.949.52

Profitability

MetricKRROPLYX
Gross margin33.04%0.00%
Operating margin-1366.43%0.00%
Net margin-4477.08%0.00%
ROE-103.31%-62.61%
ROIC-50.17%-47.75%

Growth (annualized)

MetricKRROPLYX
Revenue CAGR (5Y)-41.67%N/A
Total return CAGR (5Y)-50.72%N/A

Go deeper

Full KRRO analysisFull PLYX analysisInteractive comparison tool

Dig into the metrics

Korro Bio ROEPolaryx Therapeutics, Inc. Common Stock ROEKorro Bio operating marginPolaryx Therapeutics, Inc. Common Stock operating marginKorro Bio revenue growthPolaryx Therapeutics, Inc. Common Stock revenue growthKorro Bio free cash flowPolaryx Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.